Live News EQUITY FLASH M impact Nov 04, 2026, 09:03 PM UTC Maravai LifeSciences Q3 Revenue Reaches $45.9 Million Q3 adjusted EBITDA was $5.8 million, versus the IBES estimate of $512.9 thousand. MRVI SquawkNews Desk